[Patient education in psychiatry].

A nursing team from the day hospital of the Paris association for mental health assistance has been providing multi-disciplinary care to patients presenting serious personality disorders. For more than 10 years it has carried out action aimed at improving treatment compliance which is recognised in the framework of a therapeutic patient education programme.

[Long-term follow-up of the treatment of high anal fistulas using fibrin glue].

Aim Of The Study: Many of the treatments proposed for trans-sphincteric and suprasphincteric anal fistulas are complex and often associated with permanent damage to the sphincter mechanism. In this study, we evaluate the long-term stability of fistula closure using fibrin glue.

Materials And Methods: Forty-five consecutive patients (mean age 41.

[Laparoscopic cholecystectomy with transgastric gallbladder extraction: a new therapeutic approach].

Objective: To evaluate a newly developed cholecystectomy technique which combines classical dissection with currently available mini-instrumentation (3 and 5 mm) and removal of the gallbladder through a short gastrotomy.

Methods: After a feasibility study, we set up a protocol for this procedure using instrumentation currently available on the market. The resected gallbladder was removed through a short gastrotomy on the anterior gastric wall, thereby minimizing abdominal wall trauma and permitting the patient to resume physical activity more quickly with no risk of trocar herniation.

[Biological fibrin used in anal fistulas: 31 patients].

Aim Of The Study: The different treatments proposed for transsphincteric and suprasphincteric cryptoglandular anal fistulas are often complex and often associated with complications. After one or two stage anal fistulotomy, the risk of change in fecal continence ranks from 30% to 40%. This rate is lower (10%) with transanal advancement flap repair technique.

[The importance of lymph node dissection in medullary thyroid macrocarcinomas].

Unlabelled: Medullary thyroid carcinoma (MTC) is often regarded as good medium-term forecast. The 5- and 10-years survival rates are, respectively, appraised at 78-85% and 70-78%. These rates take no care, however, of the fact that 50-56% of the patients keep a pathological calcitonine (CT) level giving evidence of an evolutive disease.